Processa Pharmaceuticals Inc. (PCSA)
NASDAQ · Healthcare
Processa Pharmaceuticals Inc. Net Income 2012–2022
Processa Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2012 to 2023. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Processa Pharmaceuticals Inc. net income for the quarter ending March 31, 2023 was -4.0 M, a 24.63% increase year-over-year.
- Processa Pharmaceuticals Inc. net income for the twelve months ending March 31, 2023 was -7.7 M, a 76.97% increase year-over-year.
- Processa Pharmaceuticals Inc. annual net income for 2022 was -27.4 M, a 139.98% increase from 2021.
- Processa Pharmaceuticals Inc. annual net income for 2021 was -11.4 M, a 496.09% increase from 2016.
- Processa Pharmaceuticals Inc. annual net income for 2016 was -1.9 M, a 42.85% decrease from 2015.
- Processa Pharmaceuticals Inc. annual net income for 2015 was -3.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Processa Pharmaceuticals Inc. Net Income — FAQ
Processa Pharmaceuticals Inc. (PCSA) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Processa Pharmaceuticals Inc.'s net income?
Processa Pharmaceuticals Inc. (PCSA) reported net income of -$27M for fiscal 2022.
Where can I see PCSA's net income history?
The chart and table above show Processa Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.